Literature DB >> 23076526

A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Muzeyyen Izmirli1.   

Abstract

5,10-Methlenetetrahydrofolate reductase (MTHFR) is one of the most important enzymes for folate metabolism. This enzyme is mapped on chromosome 1, which is located at the end of the short arm (1p36.3). The C677T and A1298C are MTHFR polymorphisms that decrease in vitro MTHFR enzyme activity. Folate metabolism plays a key role in cell metabolism. These reactions are associated with purine-pyrimidine synthesis: DNA, RNA, and protein methylation. Polymorphism is also a factor in biodiversity, and be affected by ethnic heritage and geographic locale. In the case of unknown outcomes, not only should all geographical regions be investigated to ascertain biodiversity, but all populations as well to fully understand the variations in the effect. PUBMED was searched from January 2006 to December 2011 to develop an investigatory pursuit strategy. MTHFR, cancer, C677T, A1298C, and polymorphisms were key words used to focus the search. The literature review included all published relevant cancer types and MTHFR polymorphisms for that 5 years period. All selected polymorphisms data for cancer types was listed in tables for easy access and retrieval.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076526     DOI: 10.1007/s11033-012-2101-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  181 in total

1.  Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma.

Authors:  Chi-Jung Chung; Yeong-Shiau Pu; Chien-Tien Su; Hui-Wen Chen; Yung-Kai Huang; Horng-Sheng Shiue; Yu-Mei Hsueh
Journal:  Cancer Causes Control       Date:  2010-06-08       Impact factor: 2.506

2.  Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers.

Authors:  Vidudala V T S Prasad; Harpreet Wilkhoo
Journal:  Onkologie       Date:  2011-08-22

3.  Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study.

Authors:  Bethany R Van Guelpen; Sara M Wirén; Anders R J Bergh; Göran Hallmans; Pär E Stattin; Johan Hultdin
Journal:  Eur J Cancer Prev       Date:  2006-02       Impact factor: 2.497

4.  Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes.

Authors:  Federica Gemignani; Stefano Landi; Neonilia Szeszenia-Dabrowska; David Zaridze; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Lenka Foretova; Vladimir Janout; Vladimir Bencko; Valérie Gaborieau; Lydie Gioia-Patricola; Ilaria Bellini; Roberto Barale; Federico Canzian; Janet Hall; Paolo Boffetta; Rayjean J Hung; Paul Brennan
Journal:  Carcinogenesis       Date:  2007-01-27       Impact factor: 4.944

5.  Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer.

Authors:  Naushad Shaik Mohammad; Rupasree Yedluri; Pavani Addepalli; Suryanarayana Raju Gottumukkala; Raghunadha Rao Digumarti; Vijay Kumar Kutala
Journal:  Mol Cell Biochem       Date:  2010-11-27       Impact factor: 3.396

6.  One-carbon metabolism-related gene polymorphisms and risk of breast cancer.

Authors:  Takeshi Suzuki; Keitaro Matsuo; Kaoru Hirose; Akio Hiraki; Takakazu Kawase; Miki Watanabe; Toshinari Yamashita; Hiroji Iwata; Kazuo Tajima
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

7.  Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.

Authors:  Takeshi Suzuki; Keitaro Matsuo; Akio Hiraki; Toshiko Saito; Shigeki Sato; Yasushi Yatabe; Tetsuya Mitsudomi; Toyoaki Hida; Ryuzo Ueda; Kazuo Tajima
Journal:  Carcinogenesis       Date:  2007-04-29       Impact factor: 4.944

8.  DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR.

Authors:  Meng Hua Tao; Peter G Shields; Jing Nie; Catalin Marian; Christine B Ambrosone; Susan E McCann; Mary Platek; Shiva S Krishnan; Bin Xie; Stephen B Edge; Janet Winston; Dominica Vito; Maurizio Trevisan; Jo L Freudenheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

9.  Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers.

Authors:  Shih-Ching Chang; Pei-Ching Lin; Jen-Kou Lin; Shung-Haur Yang; Huann-Sheng Wang; Anna Fen-Yau Li
Journal:  Int J Colorectal Dis       Date:  2006-08-29       Impact factor: 2.796

10.  Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population.

Authors:  Lian-Hua Cui; Min-Ho Shin; Hee Nam Kim; Hye-Rim Song; Jin-Mei Piao; Sun-Seog Kweon; Jin-Su Choi; Woo-Jun Yun; Young-Chul Kim; In-Jae Oh; Kyu-Sik Kim
Journal:  BMC Med Genet       Date:  2011-02-22       Impact factor: 2.103

View more
  22 in total

1.  Determinants of folate and vitamin B12 plasma levels in the French E3N-EPIC cohort.

Authors:  Jordi de Batlle; Marco Matejcic; Veronique Chajes; Hortensia Moreno-Macias; Amina Amadou; Nadia Slimani; David G Cox; Françoise Clavel-Chapelon; Guy Fagherazzi; Isabelle Romieu
Journal:  Eur J Nutr       Date:  2016-12-21       Impact factor: 5.614

2.  Polymorphisms in the MTHFR gene are associated with breast cancer risk and prognosis in a Chinese population.

Authors:  Qing Lu; Ke Jiang; Qiong Li; Ya-Jie Ji; Wei-Li Chen; Xiao-Hong Xue
Journal:  Tumour Biol       Date:  2015-01-08

Review 3.  TLR4 Polymorphisms and Expression in Solid Cancers.

Authors:  Nilesh Pandey; Alex Chauhan; Neeraj Jain
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

4.  Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population.

Authors:  Xiaosheng Qi; Xing Sun; Junming Xu; Zhaowen Wang; Jinyan Zhang; Zhihai Peng
Journal:  Tumour Biol       Date:  2014-01-03

Review 5.  One-carbon metabolism and ionizing radiation: a multifaceted interaction.

Authors:  Isabelle R Miousse; Julia Tobacyk; Stepan Melnyk; S Jill James; Amrita K Cheema; Marjan Boerma; Martin Hauer-Jensen; Igor Koturbash
Journal:  Biomol Concepts       Date:  2017-05-24

Review 6.  Germline oncopharmacogenetics, a promising field in cancer therapy.

Authors:  Chiara Pesenti; Milena Gusella; Silvia M Sirchia; Monica Miozzo
Journal:  Cell Oncol (Dordr)       Date:  2015-01-09       Impact factor: 6.730

7.  The methylenetetrahydrofolate reductase (MTHFR) 677 C>T polymorphism increases the risk of developing chronic myeloid leukemia-a case-control study.

Authors:  Claudia Bănescu; Mihaela Iancu; Adrian P Trifa; Ioan Macarie; Delia Dima; Minodora Dobreanu
Journal:  Tumour Biol       Date:  2014-12-16

8.  The Studies of Prognostic Factors and the Genetic Polymorphism of Methylenetetrahydrofolate Reductase C667T in Thymic Epithelial Tumors.

Authors:  Miaolong Yan; Jiayuan Wu; Min Xue; Juanfen Mo; Li Zheng; Jun Zhang; Zhenzhen Gao; Yi Bao
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

9.  DNA methylation status of the methylenetetrahydrofolate reductase gene promoter in peripheral blood of end-stage renal disease patients.

Authors:  Maivel Ghattas; Fatma El-Shaarawy; Noha Mesbah; Dina Abo-Elmatty
Journal:  Mol Biol Rep       Date:  2013-12-21       Impact factor: 2.316

10.  Polymorphisms of methylenetetrahydrofolate reductase and glutathione S-transferase are not associated with the risk of papillary thyroid cancer in Korean population.

Authors:  Sun-Seog Kweon; Min-Ho Shin; Hee-Nam Kim; Soo-Hyun Kim; Ho-Cheol Kang
Journal:  Mol Biol Rep       Date:  2014-02-18       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.